BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar N, Sood D, Chandra R. Vaccine Formulation and Optimization for Human Herpes Virus-5 through an Immunoinformatics Framework. ACS Pharmacol Transl Sci 2020;3:1318-29. [PMID: 33344905 DOI: 10.1021/acsptsci.0c00139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Khan MS, Khan IM, Ahmad SU, Rahman I, Khan MZ, Khan MSZ, Abbas Z, Noreen S, Liu Y. Immunoinformatics design of B and T-cell epitope-based SARS-CoV-2 peptide vaccination. Front Immunol 2022;13:1001430. [PMID: 36685569 DOI: 10.3389/fimmu.2022.1001430] [Reference Citation Analysis]
2 Kuri PR, Goswami P. Current Update on Rotavirus in-Silico Multiepitope Vaccine Design. ACS Omega 2023;8:190-207. [PMID: 36643547 DOI: 10.1021/acsomega.2c07213] [Reference Citation Analysis]
3 Awasthi A, Kumar N, Mishra A, Ravi R, Dalal A, Shankar S, Chandra R. Noscapine–Amino Acid Conjugates Suppress the Progression of Cancer Cells. ACS Pharmacol Transl Sci 2022. [DOI: 10.1021/acsptsci.2c00172] [Reference Citation Analysis]
4 Sehrawat H, Kumar N, Panchal S, Kumar L, Chandra R. Imperative persistent interaction analysis of anticancer noscapine-ionic liquid with calf thymus DNA. Int J Biol Macromol 2022;220:415-25. [PMID: 35985396 DOI: 10.1016/j.ijbiomac.2022.08.106] [Reference Citation Analysis]
5 Ghahremanian S, Rashidi MM, Raeisi K, Toghraie D. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. J Mol Liq 2022;354:118901. [PMID: 35309259 DOI: 10.1016/j.molliq.2022.118901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rahnama S, Azimzadeh Irani M, Amininasab M, Ejtehadi MR. S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study. Sci Rep 2021;11:15162. [PMID: 34312429 DOI: 10.1038/s41598-021-94602-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Abdul-Hammed M, Adedotun IO, Falade VA, Adepoju AJ, Olasupo SB, Akinboade MW. Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (Mpro). Virusdisease 2021;:1-15. [PMID: 34226871 DOI: 10.1007/s13337-021-00717-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
8 Mugunthan SP, Harish MC. Multi-epitope-Based Vaccine Designed by Targeting Cytoadherence Proteins of Mycoplasma gallisepticum. ACS Omega 2021;6:13742-55. [PMID: 34095666 DOI: 10.1021/acsomega.1c01032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
9 Singh A, Kumar N, Singh S, Sewariya S, Sharma MK, Chandra R. High-valued pyrazinoindole analogues: Synthesis, antibacterial activity, structure activity relationship and molecular dynamics analyses. Results in Chemistry 2021;3:100194. [DOI: 10.1016/j.rechem.2021.100194] [Reference Citation Analysis]
10 Rajapaksha H, Perera BT, Meepage J, Perera RT, Dissanayake C. Mitigate the cytokine storm due to the severe COVID-19: A computational investigation of possible allosteric inhibitory actions on IL-6R and IL-1R using selected phytochemicals. Eur J Chem 2020;11:351-63. [DOI: 10.5155/eurjchem.11.4.351-363.2043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]